1-3 of 3
Petra Belohlavkova, MD
Close
Sort by
Journal Articles

Genotypes of the Gene Encoding the Membrane Transporter SLC22A4 Are Associated with Molecular Relapse-Free Survival after Discontinuation of Imatinib Therapy in Patients with Chronic Myeloid Leukemia

Katerina Machova, Ali Albeer, Vaclava Polivkova, Katerina Vlcanova, Alice Fabarius, PhD, Hana Klamová, MD PhD, Birgit Spiess, Cornelius Waller, Tim H Brümmendorf, MD, Jolanta Dengler, MD, Volker Kunzmann, MD PhD, Andreas Burchert, MD, Petra Bělohlávková, MD PhD, Satu Mustjoki, MD PhD, Edgar Faber, MD, Jiri Mayer, MD, Daniela Žáčková, MD PhD, Panayiotis Panayiotidis, MD, Johan Richter, MD PhD, Henrik Hjorth-Hansen, MD, Susanne Saussele, MD, Markus Pfirrmann, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1647.
https://doi.org/10.1182/blood-2019-129710
Published: 2019
Journal Articles

Ponatinib Treatment in CML and Ph+ ALL Patients: Real-Life Data from the Czech Registries

Eva Koriťáková, RNDr., PhD, Michael Doubek, MD PhD, Edgar Faber, MD PhD, Daniela Žáčková, MD PhD, Jan M. Horáček, MD PhD, Petra Bělohlávková, MD PhD, Eduard Cmunt, MD PhD, František Folber, MD PhD, Pavel Jindra, MD PhD, Hana Klamová, MD PhD, Zdeněk Kořístek, MD PhD, Lukáš Stejskal, MD, Tomáš Szotkowski, MD PhD, Cyril Šálek, MD PhD, Renata Kellnerová, MD PhD, Marika Chrápavá, Mgr.
Journal: Blood
Blood (2019) 134 (Supplement_1): 5905.
https://doi.org/10.1182/blood-2019-126395
Published: 2019
Journal Articles

New Mutation in ALAS2 as the Cause of X-Linked Sideroblastic Anemia Responsive to Pyridoxine: Comparison of ALAS2-Defective and DMT1-Defective BFU-E Growth.

Jana Kucerova, MSc, Monika Horvathova, MSc, PhD, Petra Belohlavkova, MD, Jaroslav Cermak, M.D., Ph.D., Vladimir Divoky, PhD
Journal: Blood
Blood (2009) 114 (22): 4051.
https://doi.org/10.1182/blood.V114.22.4051.4051
Published: 2009